Shares of Trex (NYSE:TREX) fell 2.8% in extended trading Monday after the decking and railing manufacturer posted second-quarter results that beat Wall Street’s expectations but revealed tightening ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Sept 18 (Reuters) - Drug developers Retension Pharmaceuticals and TRex Bio filed their paperwork for U.S. initial public offerings on Friday, reinforcing the biotech pipeline for the fall IPO window.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results